Longwood Capital Partners »

Brainstorm Cell Therapeutics shares owned by Longwood Capital Partners

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Longwood Capital Partners from 13F filings

Historical chart of Longwood Capital Partners investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Longwood Capital Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $825k 2.5k 330.00